Afton Scientific.

Afton Scientific.

cGMP aseptic drug manufacturing and fills

Overview

Afton Scientific operates a cGMP aseptic drug manufacturing facility in Charlottesville, VA, offering Grade A/Class 100 processing and automated aseptic filling for vials sized 1–100 mL, with production runs from 100 to 15,000 units. AnovaFill by Afton Scientific provides pre-sterilized, Ready-To-Fill cGMP sterile vials for customers who perform their own fills. All equipment is validated to cGMP standards and the facility is inspected by FDA and MHRA, supporting both contract manufacturing and sterile component supply for a global client base. Their aim is to provide safe, compliant, scalable aseptic filling solutions and sterile vials to pharmaceutical and biotech companies worldwide.

Significant Headcount Growth

About Afton Scientific.

Simplify's Rating
Why Afton Scientific. is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Charlottesville, Virginia

Founded

1991

Get referred to Afton Scientific.

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • October 2024 brought a $200 million expansion announcement and hundreds of new jobs.
  • March 2025 hires Jason Spacek and Jesse Boyd to accelerate commercial and financial scale.
  • Current recruiting across QA, engineering, and aseptic operations signals active expansion, not retrenchment.

What critics are saying

  • FDA 483s in April 2023 and October 2023 expose recurring quality-system fragility.
  • The 400,000-square-foot expansion needs flawless execution; delays would starve promised 200-job growth.
  • CDMO dependence on a few sterile-injectable customers creates existential utilization risk if one program slips.

What makes Afton Scientific. unique

  • Charlottesville-based sterile fill-finish CDMO with Grade A/Class 100 processing.
  • Arlington Capital took majority control in January 2024, backing regulated-industry scaling.
  • Ready-To-Fill sterile vials and small-batch commercial fills from 100 to 15,000 units.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

24%

1 year growth

24%

2 year growth

24%
WVIR
Sep 30th, 2025
Afton Scientific breaks ground on $200 million expansion in Albemarle

Afton Scientific, a manufacturer of sterile injectable drugs, is investing $200 million to expand its current facility in the County, creating at least 200 jobs and increasing its square footage by about eight times its current size.

Contraline
Apr 24th, 2025
Contraline News

CHARLOTTESVILLE, Virginia — Contraline, a biotechnology company developing a novel male contraceptive, announced it has raised $2.25 million in Seed funding.

BioSpace
Mar 28th, 2025
Afton Scientific, Llc Announces The Appointment Of Jason Spacek And Jesse Boyd As Chief Commercial Officer And Chief Financial Officer

Charlottesville, VA – March 27, 2025 – Afton. Scientific (“Afton”), a leading pharmaceutical CDMO specializing in sterile. injectables, is pleased to announce the appointments of Jason Spacek as Chief

Fierce Pharma
Oct 10th, 2024
Scottish CMO Symbiosis' £1.2M expansion to double production footprint, add 50 new jobs

Earlier this week, Afton Scientific announced plans to spend $200 million to expand its sterile and aseptic filling manufacturing plant in Charlottesville, Virginia.

Fierce Pharma
Oct 7th, 2024
Afton Scientific eyes $200M plant expansion, 200 new jobs in Virginia

Afton Scientific eyes $200M plant expansion, 200 new jobs in Virginia.

Recently Posted Jobs

Sign up to get curated job recommendations

Afton Scientific. is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →